An innovative floating gastro retentive dosage system: Formulation and in vitro evaluation

International Journal of Pharmaceutics

Volumn 378, Issue 1-2, 2009, Pages 23-29

  Sauzet, C ^a,b   Claeys Bruno, M ^b   Nicolas, M ^c   Kister, J ^b   Piccerelle, P ^a   Prinderre, P ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b AIX MARSEILLE UNIVERSITÉ   (France)

^c AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

Experimental design; Floating tablet; Gastro retentive dosage form; Hydrophobic dusty powder; Wet granulation

Indexed keywords

AEROSIL; POVIDONE; STEARIC ACID; THEOPHYLLINE;

ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG GRANULATION; DRUG SOLUBILITY; IN VITRO STUDY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; TABLET FORMULATION; TABLET POROSITY;

ADMINISTRATION, ORAL; CHEMISTRY, PHARMACEUTICAL; EXCIPIENTS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; PHARMACEUTICAL PREPARATIONS; POROSITY; SOLUBILITY; TABLETS; TECHNOLOGY, PHARMACEUTICAL;

EID: 67650726583     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.05.027     Document Type: Article

References (33)

1. Abrahamsson B., Alpsten M., and Hugosson M. Absorption, gastrointestinal transit, and tablet erosion of felodipine extended-release (ER) tablets. Pharm. Res. 10 (1993) 709-714
2. Afargan, M., Kirmayer, D., Lapidot, N., Friedman, M., Hoffman, A., 2006. Patent no. WO 2006072948.
3. Bardonnet P., Faivre V., Pugh W., Piffaretti J., and Falson F. Gastroretentive dosage forms: overview and special case of Helicobacter pylori. J. Control. Release 111 (2006) 1-18
4. Berner, B., Hou Sui Yuen, E., 2004. US Patent no. 20040903879.
5. Box G., and Wilson K. On the experimental attainment of optimum conditions. J. R. Stat. Soc. B 13 (1951) 1-45
6. Cornell J. Experiments with Mixtures: Designs, Models, and the Analysis of Mixture Data (1990), Willey, New York
7. Curatolo, W., Lo, J. 1988. US Patent no. 19880200801.
8. Desai S., and Bolton S. A floating controlled-release drug delivery systems: in vitro-in vivo evaluation. Pharm. Res. 10 (1993) 1321-1325
9. Droesbeke, J.F., Montgomery, D., 1997. Plans d'expériences: Applications à l'entreprise. Editions Technip.
10. Fedorov V. Theory of Optimal Experiments (1972), Academic Press, New York
11. Fukuda M., Peppas N., and McGinity J. Floating hot-melt extruded tablets for gastroretentive controlled drug release system. J. Control. Release 115 (2006) 121-129
12. Hwang S.J., Park H., and Park K. Gastric retentive drug-delivery systems. Ther. Drug Carrier Syst. 15 (1998) 243-284
13. Kagan L., and Hoffman A. Systems for region selective drug delivery in gastrointestinaltract: biopharmaceutical considerations. Expert Opin. Drug Deliv. 5 (2008) 681-692
14. Khosla R., Feely L., and Davis S.G.-d. Int. J. Pharm. 53 (1989) 107-117
15. Kiefer J., and Wolfowitz J. Optimum designs in regression problems. Ann. Math. Stat. 30 (1959) 271-294
16. Klausner A., Eyal S., Lavy E., Friedman M., and Hoffman A. Novel levodopa gastroretentive dosage form: in-vivo evaluation in dogs. J. Control. Release 88 (2003) 117-126
17. Mathieu D., Nony J., and Phan-Tan-Luu R. NemrodW V2000 (1999), LPRAI, Marseille, France
18. Mitchell T. An algorithm for the construction of D-optimal experimental designs. Technometrics 16 (1974) 203-210
19. O'Reilly S., Wilson C., and Hardy J. The influence of food on the gastric emptying of multiparticulate dosage forms. Int. J. Pharm. 34 (1987) 213-216
20. Prinderre, P., 2008. FR Patent no. EP 08290529.
21. Sangekar S., Vadino W.A., Chaudry I., Parr A., Beihn R., and Digenis G. Evaluation of the effect of food and specific gravity of tablets on gastric retention time. Int. J. Pharm. 35 (1987) 187-197
22. Scheffé H. Simplex-centroid design for experiments with mixtures. J. R. Stat. Soc. B 25 (1963) 235-263
23. Sonobe, T., Watanabe, S., 1989. JP Patent no. JP 19890225245.
24. Streubel A., Siepmann J., and Bodmeier R. Floating microparticles based on low density foam powder. Int. J. Pharm. 241 (2002) 279-292
25. Streubel A., Siepmann J., and Bodmeier R. Floating matrix tablets based on low density foam powder: effects of formulation and processing parameters on drug release. Eur. J. Pharm. Sci. 18 (2003) 37-45
26. Streubel A., Siepmann J., and Bodmeier R. Multiple unit gastroretentive drug delivery systems: a new preparation method for low density microparticles. J. Microencapsul. 20 (2003) 329-347
27. Struebel A., Siepmann J., and Bodmeier R. Gastroretentive drug delivery systems. Expert Opin. Drug Deliv. 3 (2006) 217-233
28. Talwar, N., Sen, H., Staniforth, J., 2000. WO Patent no. WO 0015198.
29. Timmermans, J., 1991. Floating Hydrophillic Matrix Dosage Forms for Oral use: Factors Controlling Their Buoyancy and Gastric Residence Capabilities. Ph.D. Thesis. University of Brussels, Belgium.
30. Timmermans J., and Moës A. How well do floating dosage forms float?. Int. J. Pharm. 62 (1990) 207-216
31. Timmermans J., and Moës A. Measuring the resultant-weight of an immersed test material: I. Validation of an apparatus and a method dedicated to pharmaceutical applications. Acta Pharm. Technol. 36 (1990) 171-175
32. Timmermans J., and Moës A. Measuring the resultant-weigthof an immersed test material: II. Examples of kinetic determination applied to monolithic dosage forms. Acta Pharm. Technol. 36 (1990) 176-180
33. Vanderbist, F., Baudier, P., Deboeck, A., Amighi, K., Goole, J., 2007. BE Patent no. WO 2007106960.